Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: PLEURAL NEOPLASMS - DIAGNOSIS , . Treffer: 5
2016
Geltner, C; Errhalt, P; Baumgartner, B; Ambrosch, G; Machan, B; Eckmayr, J; Klikovits, T; Hoda, MA; Popper, H; Klepetko, W; Austrian Mesothelioma Interest Group (AMIG)
Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG).
Wien Klin Wochenschr. 2016; 128(17-18):611-617
Doi: 10.1007/s00508-016-1080-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2011
Watzka, SB; Posch, F; Pass, HI; Huflejt, M; Bernhard, D; Hannigan, GE; Müller, MR
Detection of integrin-linked kinase in the serum of patients with malignant pleural mesothelioma.
J Thorac Cardiovasc Surg. 2011; 142(2):384-389
Doi: 10.1016/j.jtcvs.2011.04.034
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Watzka, SB; Setinek, U; Stubenberger, EB; Totsch, M; Dekan, G; Marcher, M; Fleck, T; Muller, MR
Integrin-linked kinase, phosphorylated AKT and the prognosis of malignant pleural mesothelioma
EUR J CARDIO-THORAC SURG. 2011; 39(2): 180-184.
Doi: 10.1016/j.ejcts.2010.05.007
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2008
Dacic, S; Kothmaier, H; Land, S; Shuai, Y; Halbwedl, I; Morbini, P; Murer, B; Comin, C; Galateau-Salle, F; Demirag, F; Zeren, H; Attanoos, R; Gibbs, A; Cagle, P; Popper, H
Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas.
Virchows Arch. 2008; 453(6): 627-635.
Doi: 10.1007/s00428-008-0689-3
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1987
Popper, H; Wirnsberger, G; Hoefler, H; Denk, H
Immunohistochemical and histochemical markers of primary lung cancer, lung metastases, and pleural mesotheliomas.
Cancer Detect Prev. 1987; 10(3-4):167-174
Web of Science
PubMed
Google Scholar